Joel Morganroth

发表

Cardiovascular complaints. Correlation with cardiac arrhythmias on 24-hour electrocardiographic monitoring.

E. Michelson, J. Morganroth, S. Zeldis, 1980, Chest.

Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular function.

S. Spielman, A. Greenspan, K. F. Discigil, 1985, Journal of the American College of Cardiology.

Effect of single ascending, supratherapeutic doses of sparfloxacin on cardiac repolarization (QTc interval).

G. Talbot, J. Morganroth, M. Dorr, 1999, Clinical therapeutics.

Electrocardiographic Findings in Patients with Obstructive and Nonobstructive Hypertrophic Cardiomyopathy

L. Horowitz, M. Josephson, E. Michelson, 1978, Circulation.

Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients.

A L Waldo, Y Pawitan, Y. Pawitan, 1991, Journal of the American College of Cardiology.

Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event.

D L Kunze, W. Crumb, A. Brown, 1993, The American journal of cardiology.

Effects of intravenous infusion of esmolol and propranolol on biventricular performance at rest and during exercise as assessed by quantitative radionuclide angiography.

A. Hakki, A. Iskandrian, J. Morganroth, 1985, The American journal of cardiology.

Relationship of atrial fibrillatory wave amplitude to left atrial size and etiology of heart disease. An old generalization re-examined.

J. Kastor, Joel Morganroth, M. E. Josephson, 1979, American heart journal.

Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability.

J. Ruskin, S. Ruberg, C. Pratt, 1996, American heart journal.

Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram.

L. Horowitz, J. Morganroth, Joel Morganroth, 1984, The American journal of cardiology.